Ledger.Open graph →
SEC Form D · filed July 19, 2018

Antiva Biosciences, Inc

Offering
$15.0M
Sold
$15.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Raju D. Gadiraju, Ph.D · South San Francisco, CAExecAaron D. Wirsing · Fenton, MIDirectorBenjamin P. Rovinski · South San Francisco, CADirectorSteven T. Krause · Fenton, MIExecAmish J. Jani · Philadelphia, PAExecAllison B. Nolan · Grand Cayman, Cayman IslandsDirectorBenjamin P. Rovinski · South San Francisco, CADirectorRaju D. Gadiraju, Ph.D · South San Francisco, CAExecDavid P. Kabakoff, Ph.D · South San Francisco, CADirectorMichael D. Cannon · Del Mar, CADirectorWende S. Hutton · South San Francisco, CADirectorVinzenz P. Ploerer · South San Francisco, CADirectorGail Maderis · South San Francisco, CAExec · DirectorOranee D. Daniels · South San Francisco, CAExecTing P. Jia · South San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗